Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The report details the trend, potential and market size of Infantile Spasm Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Infantile Spasm Treatmentmarket, defines the market attractiveness level of Infantile Spasm Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Infantile Spasm Treatment industry, describes the types of Infantile Spasm Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Infantile Spasm Treatment market and the development prospects and opportunities of Infantile Spasm Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Infantile Spasm Treatment market in Chapter 13.
By Player:
Retrophin
Anavex Life Sciences
Catalyst Pharmaceuticals
Valerion Therapeutics
Orphelia Pharma
Mallinckrodt
Insys Therapeutics
GW Pharmaceuticals
H Lundbeck
By Type:
Oral
Parenteral
By End-User:
Hospital
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Infantile Spasm Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Infantile Spasm Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Infantile Spasm Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Infantile Spasm Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Infantile Spasm Treatment Market Analysis and Outlook to 2022
-
7.1 Global Infantile Spasm Treatment Consumption (2017-2022)
-
7.2 United States Infantile Spasm Treatment Consumption (2017-2022)
-
7.3 Europe Infantile Spasm Treatment Consumption (2017-2022)
-
7.4 China Infantile Spasm Treatment Consumption (2017-2022)
-
7.5 Japan Infantile Spasm Treatment Consumption (2017-2022)
-
7.6 India Infantile Spasm Treatment Consumption (2017-2022)
-
7.7 South Korea Infantile Spasm Treatment Consumption (2017-2022)
8 Region and Country-wise Infantile Spasm Treatment Market Analysis and Outlook to 2028
-
8.1 Global Infantile Spasm Treatment Consumption Forecast (2022-2028)
-
8.2 United States Infantile Spasm Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Infantile Spasm Treatment Consumption Forecast (2022-2028)
-
8.4 China Infantile Spasm Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Infantile Spasm Treatment Consumption Forecast (2022-2028)
-
8.6 India Infantile Spasm Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Infantile Spasm Treatment Consumption Forecast (2022-2028)
9 Global Infantile Spasm Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Infantile Spasm Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Parenteral Consumption and Growth Rate (2017-2022)
-
9.2 Global Infantile Spasm Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Infantile Spasm Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Infantile Spasm Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Infantile Spasm Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Infantile Spasm Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Infantile Spasm Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Infantile Spasm Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Infantile Spasm Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Infantile Spasm Treatment Market Competitive Analysis
-
14.1 Retrophin
-
14.1.1 Retrophin Company Details
-
14.1.2 Retrophin Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Retrophin Infantile Spasm Treatment Product and Service
-
14.2 Anavex Life Sciences
-
14.2.1 Anavex Life Sciences Company Details
-
14.2.2 Anavex Life Sciences Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Anavex Life Sciences Infantile Spasm Treatment Product and Service
-
14.3 Catalyst Pharmaceuticals
-
14.3.1 Catalyst Pharmaceuticals Company Details
-
14.3.2 Catalyst Pharmaceuticals Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Product and Service
-
14.4 Valerion Therapeutics
-
14.4.1 Valerion Therapeutics Company Details
-
14.4.2 Valerion Therapeutics Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Valerion Therapeutics Infantile Spasm Treatment Product and Service
-
14.5 Orphelia Pharma
-
14.5.1 Orphelia Pharma Company Details
-
14.5.2 Orphelia Pharma Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Orphelia Pharma Infantile Spasm Treatment Product and Service
-
14.6 Mallinckrodt
-
14.6.1 Mallinckrodt Company Details
-
14.6.2 Mallinckrodt Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mallinckrodt Infantile Spasm Treatment Product and Service
-
14.7 Insys Therapeutics
-
14.7.1 Insys Therapeutics Company Details
-
14.7.2 Insys Therapeutics Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Insys Therapeutics Infantile Spasm Treatment Product and Service
-
14.8 GW Pharmaceuticals
-
14.8.1 GW Pharmaceuticals Company Details
-
14.8.2 GW Pharmaceuticals Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 GW Pharmaceuticals Infantile Spasm Treatment Product and Service
-
14.9 H Lundbeck
-
14.9.1 H Lundbeck Company Details
-
14.9.2 H Lundbeck Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 H Lundbeck Infantile Spasm Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Infantile Spasm Treatment
-
Figure Infantile Spasm Treatment Picture
-
Table Global Infantile Spasm Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Infantile Spasm Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Infantile Spasm Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Infantile Spasm Treatment Consumption by Country (2017-2022)
-
Figure United States Infantile Spasm Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Infantile Spasm Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Infantile Spasm Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Infantile Spasm Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Infantile Spasm Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Infantile Spasm Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Infantile Spasm Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Infantile Spasm Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Infantile Spasm Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Infantile Spasm Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Infantile Spasm Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Infantile Spasm Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Infantile Spasm Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Consumption and Growth Rate (2017-2022)
-
Figure Global Parenteral Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Parenteral Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Infantile Spasm Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Infantile Spasm Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Retrophin (Foundation Year, Company Profile and etc.)
-
Table Retrophin Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Retrophin Infantile Spasm Treatment Product and Service
-
Table Anavex Life Sciences (Foundation Year, Company Profile and etc.)
-
Table Anavex Life Sciences Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anavex Life Sciences Infantile Spasm Treatment Product and Service
-
Table Catalyst Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Catalyst Pharmaceuticals Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Catalyst Pharmaceuticals Infantile Spasm Treatment Product and Service
-
Table Valerion Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Valerion Therapeutics Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Valerion Therapeutics Infantile Spasm Treatment Product and Service
-
Table Orphelia Pharma (Foundation Year, Company Profile and etc.)
-
Table Orphelia Pharma Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Orphelia Pharma Infantile Spasm Treatment Product and Service
-
Table Mallinckrodt (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Infantile Spasm Treatment Product and Service
-
Table Insys Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Insys Therapeutics Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Insys Therapeutics Infantile Spasm Treatment Product and Service
-
Table GW Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table GW Pharmaceuticals Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table GW Pharmaceuticals Infantile Spasm Treatment Product and Service
-
Table H Lundbeck (Foundation Year, Company Profile and etc.)
-
Table H Lundbeck Infantile Spasm Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table H Lundbeck Infantile Spasm Treatment Product and Service
-
